The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform – Benzinga

This week brought a mixed bag of news for the cannabis industry.

Aphria Inc (NYSE: APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.

Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company’s co-founder and CEO Charles Bachtell.

TerrAscend Corp. (CSE: TER) (OTC: TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.

Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.

Following the report, Eric Choe, founder of StockDweebs, said Canopy Growth is well-positioned to rally on the production, distribution and sale of its cannabis products despite the recent downfall: “It relies primarily on retail traffic and the sale of medicinal and recreational cannabis products – this could boost overall sales and top-line figures once stores start opening post-COVID.”

Cantor Fitzgerald’s Pablo Zuanic seemed to disagree, noting the company has considerable downside risk following the fourth-quarter report.

See more financial results from Vibe Bioscience Ltd. (CSE: VIBE) (OTC: VBSCF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.

Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s first Virtual Cannabis Capital Conference on June 1.

For their part, ETFs closed the week on the red. Over the five trading days of the week:

  • ETFMG Alternative Harvest ETF (NYSE: MJ) lost 2%.
  • AdvisorShares Pure Cannabis ETF (NYSE: YOLO) slipped 0.37%.
  • Cannabis ETF (NYSE: THCX) dropped 3.85%.
  • Amplify Seymour Cannabis ETF (NYSE: CNBS) shed 2.83% of its value.
  • SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 2.95%.

Debra Borchardt, CEO of Green Market Report called the earnings results “staggering,” adding “It seems like it will be a long time before these companies can recover from past management decisions and give investors a company that they can believe in.”

In other news, real estate investment trust Innovative Industrials Properties (NYSE: IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.

Banking and payment technology company Hypur partnered with business software provider Odoo to streamline the cannabis purchasing process. Together they will provide modern, digital payments, and bolster point-of-sale operations. The partnership will also enable customers utilize Hypur’s new nationwide “safe checkout” feature, which was recently rolled out with Caliva, as well as online cannabis marketplace, Dutchie.

Psychedelics company Red Light Holland Corp. started trading on the Canadian Securities Exchange under the ticker symbol “TRIP,” and appointed Bruce Linton, the co-founder and former CEO of Canopy Growth, as chairman of its advisory board.

Advanced Flower Capital Management LLC confirmed its associate has provided Nature’s Medicines with $42 million in financing.

Louisiana is moving forward with a piece of legislation that would make medical marijuana move easily available in the state by authorizing recommendations from any state-licensed physician, while updating the list of qualifiable medical conditions.

House Bill 819 passed Senate vote on Wednesday by 28 to 6.

Find our cannabis, hemp and psychedelics news in Spanish on El Planteo.

More News From The Week

True Terpenes, a producer of GMP/ISO/FSSC-certified terpenes, formed a scientific advisory board (SAB) to advance research in the cannabis industry. The SAB will be focused on studying the entourage effect, where the benefits of medical cannabis can be enhanced when combined with terpenes. Board members include Dr. Ethan Russo, a cannabis and pharmaceutical scientist who specializes in the entourage effect. Dr. Russo previously worked with GW Pharmaceuticals on progressing Epidiolex and Sativex through clinical trials, becoming the first cannabis-based drug to be approved by the Food & Drug Administration.

„There is a growing body of anecdotal evidence that supports the existence of the entourage effect. The profound potential for cannabis medicine to positively impact human health compels the cannabis industry to establish scientific proof of the synergistic interaction between terpenes and cannabinoids. True Terpenes has unmatched access to the global terpenes supply chain and a proprietary library of terpene profiles that our company is contributing to these efforts,” said CEO Chris Campagna.

New Wave Holdings Corp. (CSE: SPOR) (OTC: TRMND)  announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals.

„We are looking forward to working with TheraPsil to help bring psychedelic therapy to patients in palliative care. It is through education, training, research and the championing of those patients who could benefit from access to these therapies that we will see this initiative move forward and see so many people be helped,” said Trumbull Fisher, President of New Wave.    

Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. 

„Earl uses our Premium Full Spectrum CBD and topical salve products to help manage the aches that are a result of many years of championing a professional sport,” said Kannaway® CEO Blake Schroeder. „We could not be more proud that our products have made a positive difference for him,”

A class-action lawsuit claiming Colorado-based Elixinol, LLC’s CBD products were illegal to sell under federal regulations was dismissed. The company creates, manufactures and sells various CBD products, including capsules, tinctures and dog treats. In McCarthy v Elixinol, LLC, lawyers argued that under the 2018 Farm Bill the hemp-derived CBD company had the right to transport and ship hemp. In addition, the FDA’s current regulations do not prohibit any company from selling hemp-based products. The suit was filed in the United States District Court for the Northern District of California in December 2019.

“Elixinol isn’t the only hemp and CBD company facing these unfounded class action lawsuits,” says Jonathan Miller, chair of Frost Brown Todd’s hemp industry team and general counsel of the U.S. Hemp Roundtable. “These attorneys previously earned a similar dismissal in Fausett, et al. v. Koi CBD, LLC and are working other pending cases claiming product impurities and failed drug tests. The 2018 Farm Bill made hemp legal and companies running legitimate businesses that are building this new industry should be welcomed and embraced.”

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

Check out these and many other cannabis stories on Benzinga.com/cannabis

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform – Yahoo Finance

This week brought a mixed bag of news for the cannabis industry.

APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.” data-reactid=”20″>Aphria Inc (NYSE: APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.

CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company’s co-founder and CEO Charles Bachtell.” data-reactid=”21″>Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. “In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.,” said the company’s co-founder and CEO Charles Bachtell.

TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.” data-reactid=”22″>TerrAscend Corp. (CSE: TER) (OTC: TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.

CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.” data-reactid=”23″>Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.

Following the report, Eric Choe, founder of StockDweebs, said Canopy Growth is well-positioned to rally on the production, distribution and sale of its cannabis products despite the recent downfall: “It relies primarily on retail traffic and the sale of medicinal and recreational cannabis products – this could boost overall sales and top-line figures once stores start opening post-COVID.”

Cantor Fitzgerald’s Pablo Zuanic seemed to disagree, noting the company has considerable downside risk following the fourth-quarter report.

TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.” data-reactid=”26″>See more financial results from Vibe Bioscience Ltd. (CSE: VIBE) (OTC: VBSCF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.

Benzinga’s first Virtual Cannabis Capital Conference on June 1.” data-reactid=”27″>Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s first Virtual Cannabis Capital Conference on June 1.

For their part, ETFs closed the week on the red. Over the five trading days of the week:

  • ETFMG Alternative Harvest ETF (NYSE: MJ) lost 2%.
  • AdvisorShares Pure Cannabis ETF (NYSE: YOLO) slipped 0.37%.
  • Cannabis ETF (NYSE: THCX) dropped 3.85%.
  • Amplify Seymour Cannabis ETF (NYSE: CNBS) shed 2.83% of its value.
  • SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 2.95%.

Debra Borchardt, CEO of Green Market Report called the earnings results “staggering,” adding “It seems like it will be a long time before these companies can recover from past management decisions and give investors a company that they can believe in.”

IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.” data-reactid=”36″>In other news, real estate investment trust Innovative Industrials Properties (NYSE: IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.

House Bill 819 passed Senate vote on Wednesday by 28 to 6.

El Planteo.” data-reactid=”42″>Find our cannabis, hemp and psychedelics news in Spanish on El Planteo.

More News From The Week

„There is a growing body of anecdotal evidence that supports the existence of the entourage effect. The profound potential for cannabis medicine to positively impact human health compels the cannabis industry to establish scientific proof of the synergistic interaction between terpenes and cannabinoids. True Terpenes has unmatched access to the global terpenes supply chain and a proprietary library of terpene profiles that our company is contributing to these efforts,” said CEO Chris Campagna.

TRMND)  announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals.” data-reactid=”50″>New Wave Holdings Corp. (CSE: SPOR) (OTC: TRMND)  announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals.

„We are looking forward to working with TheraPsil to help bring psychedelic therapy to patients in palliative care. It is through education, training, research and the championing of those patients who could benefit from access to these therapies that we will see this initiative move forward and see so many people be helped,” said Trumbull Fisher, President of New Wave.    

MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. ” data-reactid=”52″>Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. 

„Earl uses our Premium Full Spectrum CBD and topical salve products to help manage the aches that are a result of many years of championing a professional sport,” said Kannaway® CEO Blake Schroeder. „We could not be more proud that our products have made a positive difference for him,”

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

  • A Medicinal Cannabis Company That’s Conducting Clinical Research On Autism, Insomnia, And More
  • Poison Pills: A Common Component In Lawmaking, M&A And Now Cannabis
  • A Snapshot of America’s Medical Marijuana Marketplaces: Michigan
  • Cannabis Strain Names Are Meaningless: What Is The Industry Doing About It?
  • Virtual Benzinga Cannabis Capital Conference Offers Sneak Peek At Pot Industry’s Coronavirus Recovery
  • MindMed To Include MDMA to Research Portfolio
  • Benzinga Cannabis Capital Conference Presents: Vivien Azer, Star Marijuana Analyst
  • Benzinga Cannabis Capital Conference Presents: Isiah Thomas, NBA Legend And CBD Investor
  • Benzinga Cannabis Capital Conference Presents: From Bud to Bloom – Grow Your Business The Right Way
  • What Isiah Thomas, John Salley And Al Harrington Have In Common (Hint: It’s Not Basketball)

Aphria, Aurora And Other Big Ag Cannabis Companies Pull Out Of Jamaica – Forbes

Canadian Licensed Producers (LP) of cannabis are leaving Jamaica in droves, due in part to stalled governemental decisions on export licenses.

Aphria (TSE: APHA), is „halting all further investments in Latin America and the Caribbean,” said a former employee exclusively to Sara Brittany Somerset for Forbes online. Approximately 200 former Aphria employees were laid off last week in an effort by the company to downsize and restructure.

Canadian cannabis producer The Green Organic Dutchman (CSE: TGOD) is no longer pursuing opportunities in Jamaica so it can focus on its struggling Canadian operations, the Mississauga, Ontario-based company said, according to MJ Biz.

Aurora (TSE: ACB), a Canadian-listed cannabis company, has sold its Jamaica asset for less than its CDN$4.5 million ­valuation in order to gain capital.

“The company also accepted an offer to sell its Jamaica property for gross proceeds of CDN$3.4 million,” said Aurora in a market filing.

Aurora’s languishing property in Jamaica would have formed the headquarters for its local operations.

According to the Gleaner, Aurora also sold assets it held in other regions in order to focus on local production in Canada.

Additional unforseen hardships such as the stark implications of the novel coronavirus pandemic, which caused a sharp and rapid decline in toursim, left companies including Aphria with a glut of rotting marijuana inventory intended for the rapidly diminished retail market.

Even if the Jamaican government were to expedite the issuance of export licenses, the global market is extremely limited. The slight amount of export –such as Global Canna’s to Canada– was only permitted for medical research and development. Those miniscule export amounts do not add up to any genuine marketable or profitable volume.

Frustrated with the lack of action on the part of the Jamaican Government and its regulatory arm, the Cannabis Licensing Authority (CLA), it appears as if the Canadian cannabis companies are cutting their losses and heading home.

NACB Recommends Regional Approach to Cannabis Legalization, Tilray Plans to Close High Park Gardens Facility in Ontario: Week in Review – Cannabis Dispensary

The continued legalization of cannabis across the U.S. is expected to drive a surge in advertising spending in the coming years. Case in point, market and consumer data provider Statista projects that ad spending by cannabis companies in North America will grow from $661 million in 2018 to $3.89 billion over a 10-year period.

While growth expectations are dramatic and impressive, cannabis brands are faced with significant challenges in their marketing efforts. Many channels, including Google and Facebook, do not accept cannabis ads, and the ones that do come with many complex restrictions.

In these relatively early days of cannabis legality, out-of-home (OOH) advertising has emerged as the advertising channel of choice for cannabis brands. In addition to being one of the few remaining mediums capable of reaching a mass audience, OOH offers fewer restrictions than other channels, is cost effective for early-stage brands, and is proven to influence consumer attitudes and behaviors like web or foot-traffic to dispensaries.

But OOH planning for cannabis brands also requires awareness and real-time tracking of the ever-changing labyrinth of regulations and laws dictating where advertising can be placed and what can be shown in an ad. These laws differ not only by state, but by county and individual municipality. And with more than 1.5 million screens and displays, the U.S. OOH market is complex even for a traditional brand, let alone one that also has to navigate numerous restrictions on content and placement.

However, with investments and advancements in data aggregation technologies and the emergence of new campaign planning tools and platforms, it is possible for cannabis brands to quickly and safely leverage OOH to grow their businesses.

By adhering to these five key considerations, cannabis brands can leverage OOH safely, legally and effectively.

1. Look Before Leaping

Cannabis legalization occurs on a state-by-state basis. No two states have exactly the same sets of laws and guidelines. As a once-banned activity becomes legal in a given state, there is a rush to market with a flood of advertising activity. Take the time to truly understand the regulatory nature, and any sensitivities, before launching headlong into your advertising efforts.

2. Be Mindful of the Space You Are In

Yes, new data-driven planning tools and platforms enable the quick and easy identification of usable and compliant locations. However, even after ensuring that the selected inventory complies with all the necessary regulations, consider whether the message is truly appropriate for the community and surrounding areas where it will be seen. Just because you can promote your product on a particular OOH screen doesn’t necessarily mean you should. Criticism and community blowback come into play, even when you’re operating within your legal rights.   

3. Create a Sense of Shared Accountability

Sometimes, despite best efforts, issues arise. Have a plan in place ahead of time to manage complaints, incoming press inquiries or any other speed bumps. Establish a culture of shared accountability among all partners so that issues can be tackled quickly and effectively.

4. Leverage Partners

Today, any company can easily buy a billboard by calling up the media owner, but by working with an OOH specialist agency, cannabis brands can access a wider range of opportunities and capitalize on the experience and volume they manage to secure the very best locations and audiences for the best price. Specialist partners can also make it easier to navigate the complexities of OOH campaigns with turn-key and end-to-end solutions covering planning, execution, price negotiation, payment and reporting.

5. Ensure Every Channel Has a Seat at Your Table

Finally, too often, OOH is added on at the end of the wider planning process, as a secondary consideration or something “nice to have.” This is true both for cannabis and mainstream brands. To maximize the role of all channels in a marketing plan, bring everyone to the table from day one as the strategy is being developed. Marrying the vision from the start ensures ideas come to life across every brand communication and creates greater chance of success in delivering on business objectives. 

Shabnam Irilian is managing director for Talon Outdoor, an out-of-home agency delivering creative, technology-led and integrated OOH communications.

New Survey Previews 2020 Growing Season, Colorado OKs CBD Sales to Cannabis Dispensaries: Week in Review – Hemp Grower

Federal policy on hemp has come a long way, since the passage of the Agriculture Improvement Act of 2018 (2018 Farm Bill) and the authorization of states and tribes to legally grow, manufacture and sell the crop. But before many people even knew what cannabidiol (CBD) or other hemp-derived cannabinoids were, Vote Hemp was advocating for industrial hemp legalization and an end to Drug Enforcement Administration (DEA) raids. As it continues to push for the acceptance and use of this plant, the nonprofit organization is celebrating its 20th anniversary in 2020.

Founding and Early Years

In 1992, Eric Steenstra and Steve DeAngelo started a hemp clothing company called Ecolution. “We grew it from scratch,” Steenstra, now the president of Vote Hemp, tells Hemp Grower. “We developed a line of 100% hemp clothing coming out of Eastern Europe. … We started working with others in the industry and talking about common challenges that we were all facing, importing products, trying to source things overseas and having to import them. We knew that there was a history, that hemp had been grown here and it didn’t make a lot of sense that we couldn’t source it here and the farmers in the United States were being left out.”

Ecolution grew to more than $3 million in sales during its roughly seven years in existence, Steenstra says. However, the company had to price its products, such as hemp jeans, high. Continued growth would be dependent upon positioning the company as a fashion brand—and that would involve an extensive marketing budget and marketing experience that the team didn’t have. So, Steenstra and DeAngelo sold the company in 1999.

A group that included Steenstra and Lloyd Hart, whom Steenstra describes as a “political operative,” decided to work to change hemp law and founded Vote Hemp in 2000. “We just began working largely at the state level in the very beginning,” Steenstra says. “Then, after a couple of years, we started doing some outreach on Capitol Hill.”

David Bronner says he joined Vote Hemp’s board in 2001 after adding hemp seed oil to his business’ soap formulation in 1999. Dr. Bronner’s Magic Soaps, the company his grandfather Emanuel Bronner founded in 1948, “exists to make the world better,” he says. “That’s how we … engage with it, and the first major activist move would have been to incorporate hemp seed oil.” (Hemp seed oil contains essential omega-3 fatty acids, which are beneficial for skin health; Dr. Bronner’s conducted trials with its products containing the oil, and after receiving positive feedback, began incorporating it into many of its products.)

Working with Vote Hemp, Bronner has worked to advance the production and use of the crop, in part through helping fund legal cases.

Vote Hemp supports farmers and the hemp industry, in addition to advocating for improvements in hemp law and policy. In addition, Bronner describes Vote Hemp as “the hemp-consumer voice at the federal level.”

“Vote Hemp can really mobilize a lot of people to contact their representatives about regulations and is lobbying to improve regulations over the next [several] years,” he says.

Political Progress

In the early 2000s, two of the politicians who were outspoken about hemp legalization were third-party presidential candidates Ralph Nader and Ron Paul.

Vote Hemp helped draft the first Industrial Hemp Farming Act in 2005, introduced by then-Rep. Paul (R-TX). If passed, it would have removed hemp from the Controlled Substances Act and gave authority to the states to regulate the crop.

“Ron Paul, being a libertarian, took a states’ rights approach and a very limited-government approach to everything he did,” Steenstra says. “So, the original bill was drafted as a states’ rights bill, essentially, allowing states to regulate it, and that approach stuck through the whole process.”

The Industrial Hemp Farming Act of 2005 didn’t pass, but Steenstra says it ignited a political spark.

“That was the beginning of the process at the federal level, and we just kept building each year,” Steenstra says. “We’d go and meet with offices and kept working with state legislators at the same time. We did a lot of work in the states—early states like Colorado, North Dakota and Kentucky—we made some early attempts as well—there’s a bunch of states that tried to do that. In any case, the states were great because they helped to provide the pressure to push things at the federal level that there was interest in this.”

Vote Hemp worked on hemp bills over the years with Democrats and Republicans who were willing to reach across the aisle, Steenstra says. For instance, he points out that in the California State Assembly, Chuck DeVore, whom he described as a “very conservative” Republican, and Mark Leno, a Democrat, co-authored AB 1147. (The California State Assembly and State Senate passed the bill, but former Gov. Arnold Schwarzenegger vetoed it.)

“We saw that pattern over and over throughout the years that we were able to pair up Republicans and Democrats,” Steenstra says. “Some focused a little bit more on one type of benefit than the other, but they could both see the economic benefits, so that was great to have that bipartisan cooperation. It allowed us to really advance the policy on this.”

Throughout the years, Vote Hemp continued to work with political leaders who introduced and advocated for federal hemp legislation. Among them was U.S. Sen. Ron Wyden (D-OR), who in 2011 worked on a companion bill to the Industrial Hemp Farming Act of 2011, the fourth hemp bill Paul introduced in the U.S. House. (Paul had also introduced hemp bills in the House in 2007 and 2009.)

Then, former U.S. Rep. Jared Polis (D-CO), who is now governor of Colorado, introduced an amendment to the House version of the Agricultural Act of 2014 (2014 Farm Bill) to allow for university research into hemp, Steenstra says. It passed with the bipartisan support of 162 Democrats and 63 Republicans.

“The work that we had done, knocking on doors, meeting with staff, talking with members and educating them on what hemp was, why it had economic potential—that day was a really proud moment for me and for us as an organization because it was the first major step forward, and it woke up a lot of people,” Steenstra says.

And former Kentucky Agriculture Commissioner James Comer, someone else Vote Hemp had been working with, helped convince U.S. Sen. Mitch McConnell (R-KY) that hemp production would be a boon for the state. McConnell—at the time the Senate minority leader and now its majority leader—proceeded to push for language that made it into the 2014 Farm Bill.

“Senator McConnell was able to work through the conference process to get the language tweaked a little bit from the original Polis amendment to include departments of agriculture, at James Comer’s request, and to expand it to include the words 'pilot programs,’ and to expand the purpose to include marketing,” Steenstra says. “Those three changes were critical to allowing this to become more than just a couple of universities with a plot of hemp behind a barbed-wire fence. That’s essentially what would have ended up happening, had it not been expanded.”

Involvement in Legal Cases

Throughout the years, Vote Hemp has been involved in several court cases to support and advance the hemp industry and consumers.

  • Hemp Industries Association v. Drug Enforcement Administration. In October 2001, the Drug Enforcement Agency (DEA) “tried to ban the consumption of any product that had any THC [tetrahydrocannabinol],” Steenstra says. He and Bronner hired lawyers who successfully filed an injunction in California’s 9th Circuit Court of Appeals, and in 2004, they received a unanimous decision from the court in support of HIA’s position that hemp foods shouldn’t be banned. “Dr. Bronner’s provided the majority of funding for the case,” according to Vote Hemp’s website.
  • United States of America vs. Alexander Alex” White Plume. In 2000 and 2001, the DEA destroyed Oglala Sioux Native American Alex White Plume’s hemp crops, not recognizing an ordinance the tribe had passed in 1998 allowing for hemp cultivation on the Pine Ridge Indian Reservation in South Dakota. When White Plume planted hemp a third season, the DEA filed an injunction against him to discontinue planting. Again equipped with funds from Dr. Bronner’s, Vote Hemp got involved, and eventually, according to Steenstra, helped get the case overturned in federal court.

    Steenstra adds: “Ultimately, when the 2014 Farm Bill happened, Native Americans were left out of that. Because of the way the bill was written, in the drafting of this thing, we didn’t realize that Native Americans would be left out of this the way the original language was.That’s something we worked hard to correct—I personally worked very hard to correct—in the 2018 Farm Bill. We did get it, so as you can see now, tribes have a direct right to go and apply for the ability to regulate hemp on their reservations through the USDA.”

  • Monson v. DEA. In 2007, farmer David Monson, a Republican in the North Dakota House of Representatives, and another farmer, Wayne Hauge, filed a lawsuit against the DEA. The suit filed in North Dakota’s U.S. District Court aimed to end the DEA’s “obstruction of commercial hemp farming in the United States,” according to Vote Hemp’s site.
    „The case was ultimately not successful,” Steenstra says. “But it was a really important effort in trying to move policy forward and to educate people on this, and to have a state like North Dakota looking at this and saying, ‘Look, we see a real opportunity here for this crop, and we want to be able to grow it, and the federal government is standing in our way. We’re going to put up a fight to do that.’”

Photo courtesy of Eric Steenstra

Remaining Challenges

Although the 2018 Farm Bill legalized hemp federally and most states are choosing to set up programs, Vote Hemp is still working to advance policy on a few key issues.

One of the organization’s main priorities is to push for the revision of the U.S. definition of “hemp” to include crops with THC levels higher than the 0.3% limit set in the 2018 Farm Bill.

“Most people who look at hemp from more of a scientific standpoint recognize that varieties of hemp go up to 1% and even more, but certainly that 1% is a more reasonable line—that generally, plants under 1% still aren’t intended for getting high or anything like that,” Steenstra says.

Another priority is to integrate hemp more into existing federal programs, such as including hemp foods in school lunches. Among these foods are hemp seed, which contains healthy omega-3 and omega-6 fatty acids.

“A lot of the money that goes to USDA goes to fund commodity purchases for things that go into school lunches, that go to children all over the U.S.,” Steenstra says. “We think that hemp would be a great ingredient for that.”

A third remaining challenge is pushing for the regulation of hemp-derived products, especially cannabidiol (CBD). The 2018 Farm Bill includes cannabinoids in its definition of “hemp,” Steenstra points out, and the FDA accepted comments from the public about hemp extracts in 2019. However, the FDA holds that CBD products are illegal (though they remain largely unregulated).

“[The FDA has] done nothing but create confusion around this,” Steenstra says. “I can’t think of too many products that are more widely distributed right now than CBD. You can find it at your grocery store, your drug store, the gas station. I go get my haircut at the barber, and they’ve got CBD on the counter. It’s everywhere. So, why is FDA continuing to fail to regulate this?”

In July 2019, Vote Hemp submitted comments to the FDA on the issue of hemp-derived products. The organization’s letter stated, among other things, that CBD should be regulated like other foods or dietary supplements, “be eligible for organic certification under the USDA’s National Organic Program” and have recommendations for serving sizes.

And, as with many state officials, Vote Hemp has some concerns about the USDA’s interim final rule (IFR) that was issued in October 2019 and addresses hemp production in the U.S.

In January, Vote Hemp also sent comments to the USDA, asking the department to remedy numerous issues, such as the possibility of uncertainty in sampling and testing processes and the USDA’s stated method of collecting samples from the top third of a crop (which contains more THC than the lower parts of the plant).

In addition, Vote Hemp’s letter to the USDA addresses the agency’s ban of people participating in a state or tribal hemp program who have been convicted of a controlled-substance felony in the past 10 years.

“USDA has included a requirement for a report of the criminal history of ‘each key participant’ of an applicant,” Vote Hemp’s letter states. “We urge USDA to ensure this provision is limited to only to individual applicants or owners of a business entity when the applicant is a business entity. We recommend that USDA issue a clarification that this provision does not apply to any non-owner employees or vendors.”

Bronner, an active proponent of cannabis—regardless of THC level—and psilocybin therapy and policy reform, opposes many controlled-substance arrests and convictions to begin with. While that’s a battle of its own, policymakers are coming around to hemp.

“I think we’re finally moving into a kind of post-prohibition, rational era,” Bronner says. “For a long, long time, we had the DEA out there just constantly misrepresenting hemp and marijuana and conflating them.”

Now, new challenges arise for the hemp industry, Bronner says, like matching supply with demand. At the same time, he says hemp needs to be regulated the same as corn, soy or wheat. “I think Vote Hemp has a real role to play,” he says.

Steenstra echoes that sentiment, saying, „We’re really going to continue to focus on legislation at the state and federal level, … then working with federal agencies to turn it into a major crop and a commodity in the United States.”